Charles Schwab’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.68M | Buy |
425,781
+8,217
| +2% | +$105K | ﹤0.01% | 2338 |
|
|
2026
Q1 | $3.46M | Sell |
417,564
-11,611
| -3% | -$105K | ﹤0.01% | 2553 |
|
|
2025
Q4 | $4.12M | Sell |
429,175
-271
| -0.1% | -$2.56K | ﹤0.01% | 2534 |
|
|
2025
Q3 | $4.07M | Buy |
429,446
+9,633
| +2% | +$81.1K | ﹤0.01% | 2522 |
|
|
2025
Q2 | $3.13M | Buy |
419,813
+49,511
| +13% | +$307K | ﹤0.01% | 2519 |
|
|
2025
Q1 | $2.25M | Buy |
370,302
+5,207
| +1% | +$36K | ﹤0.01% | 2576 |
|
|
2024
Q4 | $2.84M | Sell |
365,095
-22,619
| -6% | -$169K | ﹤0.01% | 2565 |
|
|
2024
Q3 | $3.14M | Buy |
387,714
+2,226
| +0.6% | +$18.2K | ﹤0.01% | 2573 |
|
|
2024
Q2 | $2.66M | Buy |
385,488
+13,339
| +4% | +$180K | ﹤0.01% | 2601 |
|
|
2024
Q1 | $6.59M | Buy |
372,149
+6,118
| +2% | +$96.9K | ﹤0.01% | 2189 |
|
|
2023
Q4 | $5.67M | Buy |
366,031
+12,008
| +3% | +$157K | ﹤0.01% | 2256 |
|
|
2023
Q3 | $4.85M | Buy |
354,023
+17,024
| +5% | +$251K | ﹤0.01% | 2274 |
|
|
2023
Q2 | $5.81M | Sell |
336,999
-15,436
| -4% | -$316K | ﹤0.01% | 2178 |
|
|
2023
Q1 | $8.46M | Sell |
352,435
-1,257
| -0.4% | -$27.3K | ﹤0.01% | 1949 |
|
|
2022
Q4 | $6.14M | Buy |
353,692
+12,906
| +4% | +$272K | ﹤0.01% | 2113 |
|
|
2022
Q3 | $8.3M | Sell |
340,786
-733
| -0.2% | -$25.2K | ﹤0.01% | 1947 |
|
|
2022
Q2 | $10.6M | Buy |
341,519
+172
| +0.1% | +$4.58K | ﹤0.01% | 1809 |
|
|
2022
Q1 | $11.9M | Buy |
341,347
+25,705
| +8% | +$972K | ﹤0.01% | 1850 |
|
|
2021
Q4 | $18.7M | Buy |
315,642
+7,410
| +2% | +$513K | 0.01% | 1632 |
|
|
2021
Q3 | $20.5M | Buy |
308,232
+2,582
| +0.8% | +$159K | 0.01% | 1564 |
|
|
2021
Q2 | $19.3M | Buy |
305,650
+6,260
| +2% | +$352K | 0.01% | 1619 |
|
|
2021
Q1 | $15.6M | Buy |
299,390
+47,776
| +19% | +$2.91M | 0.01% | 1703 |
|
|
2020
Q4 | $11M | Buy |
251,614
+6,923
| +3% | +$330K | ﹤0.01% | 1805 |
|
|
2020
Q3 | $11.6M | Sell |
244,691
-1,453
| -0.6% | -$58.8K | 0.01% | 1583 |
|
|
2020
Q2 | $7.45M | Buy |
246,144
+23,600
| +11% | +$525K | ﹤0.01% | 1817 |
|
|
2020
Q1 | $3.8M | Buy |
222,544
+7,665
| +4% | +$134K | ﹤0.01% | 1965 |
|
|
2019
Q4 | $3.54M | Buy |
214,879
+7,386
| +4% | +$110K | ﹤0.01% | 2207 |
|
|
2019
Q3 | $3.39M | Buy |
207,493
+142,927
| +221% | +$2.86M | ﹤0.01% | 2167 |
|
|
2019
Q2 | $1.18M | Buy |
64,566
+1,402
| +2% | +$22.2K | ﹤0.01% | 2518 |
|
|
2019
Q1 | $817K | Buy |
63,164
+4,934
| +8% | +$53.6K | ﹤0.01% | 2609 |
|
|
2018
Q4 | $643K | Hold |
58,230
| – | – | ﹤0.01% | 2676 |
|
|
2018
Q3 | $746K | Buy |
58,230
+3,530
| +6% | +$50.4K | ﹤0.01% | 2707 |
|
|
2018
Q2 | $864K | Buy |
+54,700
| New | +$582K | ﹤0.01% | 2624 |
|
Other funds holding CYRX
CCM
FAM
MCO
Charles Schwab's CYRX Position: Q2 2026 in Review
Charles Schwab increased its CryoPort (CYRX) stake by 2% in Q2 2026, buying an estimated $105K and bringing the position to 425,781 shares worth $6.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2338.
Charles Schwab first reported a position in CYRX in Q2 2018 and has held it in 33 quarters since. The position peaked at $20.5M in Q3 2021. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.
- Charles Schwab held 425,781 shares of CryoPort worth $6.68M as of Q2 2026.
- Charles Schwab bought 8,217 CryoPort shares in Q2 2026, an estimated $105K.
- CryoPort made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2338 holding.
- Charles Schwab first reported a position in CryoPort in Q2 2018 and has held it in 33 quarters since.
- Charles Schwab's CryoPort position peaked at $20.5M in Q3 2021.
- 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.